Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 8, p. 694, doi. 10.3390/antibiotics13080694
- By:
- Publication type:
- Article
Works by Kalfus, Ira N.
Results: 6
1
2
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 10, p. 685, doi. 10.3390/antibiotics9100685
- By:
- Publication type:
- Article
3
Bimodal Release Ondansetron for Acute Gastroenteritis Among Adolescents and Adults: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 11, p. e1914988, doi. 10.1001/jamanetworkopen.2019.14988
- By:
- Publication type:
- Article
4
Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
5
Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.
- Published in:
- Allergy & Asthma Proceedings, 2013, v. 34, n. 2, p. 162, doi. 10.2500/aap.2013.34.3645
- By:
- Publication type:
- Article
6
Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
- Published in:
- Allergy & Asthma Proceedings, 2012, v. 33, n. 4, p. 348, doi. 10.2500/aap.2012.33.3585
- By:
- Publication type:
- Article